or
forgot password
  • cancer clinical trials in springfield, MO

  • S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
    CCOP - Cancer Research for the Ozarks

    Trial Locations
    CCOP - Cancer Research for the Ozarks
    Hulston Cancer Center at Cox Medical Center South
    St. John's Regional Health Center
    Lymphoma
    S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
    Hulston Cancer Center at Cox Medical Center South

    Trial Locations
    Hulston Cancer Center at Cox Medical Center South
    St. John's Regional Health Center
    Breast Cancer
    Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Hulston Cancer Center at Cox Medical Center South
    Springfield, Missouri 65807
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
    CCOP - Cancer Research for the Ozarks

    Trial Locations
    CCOP - Cancer Research for the Ozarks
    Hulston Cancer Center at Cox Medical Center South
    St. John's Regional Health Center
    Breast Cancer
    Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
    CCOP - Cancer Research for the Ozarks

    Trial Locations
    CCOP - Cancer Research for the Ozarks
    Hulston Cancer Center at Cox Medical Center South
    St. John's Regional Health Center
    Anal Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Cox Medical Center
    Springfield, Missouri 65807
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
    CCOP - Cancer Research for the Ozarks

    Trial Locations
    CCOP - Cancer Research for the Ozarks
    Hulston Cancer Center at Cox Medical Center South
    St. John's Regional Health Center
    Lung Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    CCOP - Cancer Research for the Ozarks

    Trial Locations
    CCOP - Cancer Research for the Ozarks
    Hulston Cancer Center at Cox Medical Center South
    St. John's Regional Health Center
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
    Cox Medical Center
    Springfield, Missouri 65807
    Endometrial Cancer
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Saint John's Hospital
    Springfield, Missouri 65804
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia
    CCOP - Cancer Research for the Ozarks

    Trial Locations
    CCOP - Cancer Research for the Ozarks
    St. John's Regional Health Center
    Endometrial Cancer, Precancerous Condition
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Ozark Health Ventures LLC dba Cancer Research for The Ozarks Springfield

    Trial Locations
    Ozark Health Ventures LLC dba Cancer Research for The Ozarks Springfield
    Saint John's Hospital
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Selumetinib in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer
    Ozark Health Ventures LLC dba Cancer Research for The Ozarks Springfield
    Springfield, Missouri 65802
    Borderline Ovarian Surface Epithelial-stromal Tumor, Ovarian Serous Cystadenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Borderline Ovarian Surface Epithelial-stromal Tumor
    Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer
    Cancer Research for the Ozarks
    Springfield, Missouri 65807
    Chemotherapy-induced Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
    CCOP - Cancer Research for the Ozarks

    Trial Locations
    CCOP - Cancer Research for the Ozarks
    Hulston Cancer Center at Cox Medical Center South
    St. John's Regional Health Center
    Brain and Central Nervous System Tumors
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Cox Medical Center
    Springfield, Missouri 65807
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Hulston Cancer Center at Cox Medical Center South
    Springfield, Missouri 65807
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
    Ozark Health Ventures LLC dba Cancer Research for The Ozarks Springfield

    Trial Locations
    Ozark Health Ventures LLC dba Cancer Research for The Ozarks Springfield
    Saint John's Hospital
    Cox Medical Center
    Neuroendocrine Carcinoma
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Ozark Health Ventures LLC dba Cancer Research for The Ozarks Springfield

    Trial Locations
    Ozark Health Ventures LLC dba Cancer Research for The Ozarks Springfield
    Saint John's Hospital
    Cox Medical Center
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Cox Medical Center
    Springfield, Missouri 65807
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    Saint John's Hospital
    Springfield, Missouri 65804
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Ozark Health Ventures LLC dba Cancer Research for The Ozarks Springfield

    Trial Locations
    Ozark Health Ventures LLC dba Cancer Research for The Ozarks Springfield
    Cox Medical Center
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer
    Cox Medical Center
    Springfield, Missouri 65807
    Anaplastic Thyroid Cancer, Recurrent Thyroid Cancer, Stage III Follicular Thyroid Cancer, Stage III Papillary Thyroid Cancer, Stage IV Follicular Thyroid Cancer, Stage IVA Follicular Thyroid Cancer, Stage IVA Papillary Thyroid Cancer, Stage IVB Follicular Thyroid Cancer, Stage IVB Papillary Thyroid Cancer, Stage IVC Follicular Thyroid Cancer, Stage IVC Papillary Thyroid Cancer, Thyroid Gland Medullary Carcinoma
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    St. John's Regional Health Center

    Trial Locations
    St. John's Regional Health Center
    Cox Health Systems
    Breast Cancer